Public sector HLL Lifecare Ltd will manufacture a device for limb immobilizer, which is considered crucial for treating a patient suffering fractures in a trauma case, the company disclosed.
The low-cost, disposable and eco-friendly limb immobilization device, under the brand name Relligo, has been developed by Biotech Consortium India Limited (BCIL), a company promoted by Department of Biotechnology at the All India Institute of Medical Sciences (AIIMS) here, a release said.
The technology for the device was transferred to HLL at a function in the Health Ministry here yesterday.
“We earnestly believe that Relligo will go a long way in fulfilling the largely unmet clinical need of trauma care segment in hospitals and health care centres across the country. It is both effective and affordable,” said Dr M Ayyappan, CMD of HLL. “Significantly, it will expand the portfolio of HLL in healthcare products.”
In any trauma case, the most common extremity injuries are fractures, dislocation, sprain, strain or contusions resulting from either blunt, penetrating or crush type of injuries, which are typically associated with road traffic accidents.
There are few products in the market addressing this need, including SAM splint, vacuum splint, wooden planks, Thomas splint and Cramer wire. Very few are available in Indian market, and those available are either not affordable or not designed keeping Indian scenario into consideration.
“Relligo will be a useful device in the Indian conditions, considering its performance of immobilization, non-hindrance during diagnostic procedures, cost and usability,” he pointed out.
AIIMS has given ethical clearance for conducting clinical trials, and it has already been successfully completed.